TD Waterhouse Canada’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Sell |
14,019
-1,083
| -7% | -$18K | ﹤0.01% | 796 |
|
|
2025
Q1 | $231K | Sell |
15,102
-497
| -3% | -$7.6K | ﹤0.01% | 765 |
|
|
2024
Q4 | $344K | Sell |
15,599
-5,100
| -25% | -$112K | ﹤0.01% | 690 |
|
|
2024
Q3 | $366K | Buy |
20,699
+3,900
| +23% | +$68.9K | ﹤0.01% | 661 |
|
|
2024
Q2 | $274K | Hold |
16,799
| – | – | ﹤0.01% | 704 |
|
|
2024
Q1 | $241K | Sell |
16,799
-300
| -2% | -$4.3K | ﹤0.01% | 738 |
|
|
2023
Q4 | $192K | Sell |
17,099
-1,707
| -9% | -$19.1K | ﹤0.01% | 686 |
|
|
2023
Q3 | $194K | Buy |
18,806
+10,750
| +133% | +$111K | ﹤0.01% | 648 |
|
|
2023
Q2 | $64.1K | Sell |
8,056
-3,774
| -32% | -$30K | ﹤0.01% | 871 |
|
|
2023
Q1 | $113K | Sell |
11,830
-327
| -3% | -$3.12K | ﹤0.01% | 746 |
|
|
2022
Q4 | $122K | Buy |
12,157
+600
| +5% | +$6.03K | ﹤0.01% | 721 |
|
|
2022
Q3 | $101K | Sell |
11,557
-450
| -4% | -$3.92K | ﹤0.01% | 774 |
|
|
2022
Q2 | $98.8K | Buy |
12,007
+2,000
| +20% | +$16.5K | ﹤0.01% | 805 |
|
|
2022
Q1 | $97.6K | Buy |
10,007
+513
| +5% | +$5K | ﹤0.01% | 850 |
|
|
2021
Q4 | $84.8K | Buy |
+9,494
| New | +$84.8K | ﹤0.01% | 910 |
|